Success Metrics

Clinical Success Rate
100.0%

Based on 9 completed trials

Completion Rate
100%(9/9)
Active Trials
3(19%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
2
13%
Ph phase_4
9
56%
Ph phase_1
2
13%
Ph not_applicable
1
6%

Phase Distribution

2

Early Stage

0

Mid Stage

11

Late Stage

Phase Distribution14 total trials
Phase 1Safety & dosage
2(14.3%)
Phase 3Large-scale testing
2(14.3%)
Phase 4Post-market surveillance
9(64.3%)
N/ANon-phased studies
1(7.1%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

100.0%

9 of 9 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

3

trials recruiting

Total Trials

16

all time

Status Distribution
Active(3)
Completed(9)
Other(4)

Detailed Status

Completed9
unknown4
Recruiting3

Development Timeline

Analytics

Development Status

Total Trials
16
Active
3
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 12 (14.3%)
Phase 32 (14.3%)
Phase 49 (64.3%)
N/A1 (7.1%)

Trials by Status

completed956%
recruiting319%
unknown425%

Recent Activity

3 active trials
Showing 5 of 16
recruitingphase_4

The Effect of InTensive Statin in Ischemic Stroke With inTracranial Atherosclerotic Plaques

NCT03753555
unknown

Expanded Access Program for R007 (Probucol) Tablets in Adults With Mitochondrial Disease and Chronic Kidney Disease

NCT06931834
completedphase_4

Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related Biomarker

NCT00823849
recruiting

Efficacy of Probucol Combined with Statins Treatment for Ischemic Stroke

NCT06604117
recruitingphase_3

Probucol for Symptomatic Intracranial and Extracranial Artery Stenosis

NCT06225752
View all 16 trials

Clinical Trials (16)

Showing 16 of 16 trials
NCT03753555Phase 4

The Effect of InTensive Statin in Ischemic Stroke With inTracranial Atherosclerotic Plaques

Recruiting
NCT06931834

Expanded Access Program for R007 (Probucol) Tablets in Adults With Mitochondrial Disease and Chronic Kidney Disease

Unknown
NCT00823849Phase 4

Study of Cilostazol and Probucol to Assess Their Effects on Atherosclerosis Related Biomarker

Completed
NCT06604117

Efficacy of Probucol Combined with Statins Treatment for Ischemic Stroke

Recruiting
NCT06225752Phase 3

Probucol for Symptomatic Intracranial and Extracranial Artery Stenosis

Recruiting
NCT01000467Phase 4

Pharmacokinetics Study for Probucol

Completed
NCT00549978Phase 4

Safety and Pharmacokinetics of Probucol and Cilostazol

Completed
NCT01291641Phase 4

Effect of Probucol and/or Cilostazol on Mean IMT in Patients With Coronary Heart dIsease

Completed
NCT02707458Phase 1

Dosage and Efficacy of Probucol-induced apoE to Negate Cognitive Deterioration

Completed
NCT00655330Not Applicable

Probucol Combined With Valsartan in Reducing Proteinuria in Diabetes Nephropathy

Unknown
NCT01013532Phase 4

PreventIon of CArdiovascular Events in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage

Unknown
NCT02483169Phase 4

PreventIon of IMT Progression in iSchemic Stroke Patients With High Risk of Cerebral HemOrrhage-IMT Study

Unknown
NCT00426348Phase 4

A Study of the Antioxidant Probucol Combined With Valsartan in Patients With IgA Nephropathy

Completed
NCT01349010Phase 3

Efficacy and Safety of Imported Probucol to Treat Hyperlipidemia

Completed
NCT01590901Phase 1

Pharmacokinetics and Safety Study of Probucol by Multiple Administration in Healthy Male Subjects

Completed
NCT01252056Phase 4

A Clinical Study to Evaluate the Efficacy and Safety of Cilostazol and Probucol in Combination on Patients With Diabetic Nephropathy

Completed

All 16 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
16